| scholarly article | Q13442814 |
| P50 | author | Prisca Boisguerin | Q55117843 |
| P2093 | author name string | Rudolf Volkmer | |
| Lars Vouilleme | |||
| Dean R. Madden | |||
| Patrick R. Cushing | |||
| P2860 | cites work | PDZ domains-glue and guide. | Q35169335 |
| PDZ domain binding selectivity is optimized across the mouse proteome | Q40191457 | ||
| NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions. | Q40258288 | ||
| Ezrin controls the macromolecular complexes formed between an adapter protein Na+/H+ exchanger regulatory factor and the cystic fibrosis transmembrane conductance regulator | Q40380183 | ||
| The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling | Q41893473 | ||
| A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR. | Q42031640 | ||
| Synthesis and screening of support-bound combinatorial peptide libraries with free C-termini: determination of the sequence specificity of PDZ domains | Q46783302 | ||
| New insights into cystic fibrosis: molecular switches that regulate CFTR | Q56680230 | ||
| Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains | Q80459449 | ||
| The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange | Q24310009 | ||
| A C-terminal motif found in the β 2 -adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na + /H + exchanger regulatory factor family of PDZ proteins | Q24316901 | ||
| Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity | Q24515074 | ||
| Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ | Q27732927 | ||
| WebLogo: A Sequence Logo Generator | Q27860646 | ||
| EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma | Q28182609 | ||
| Recognition of unique carboxyl-terminal motifs by distinct PDZ domains | Q29547580 | ||
| Small-molecule inhibitors of protein-protein interactions: progressing towards the dream | Q29617758 | ||
| Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides | Q30163803 | ||
| PDZ Domain Proteins: Plug and Play! | Q30164767 | ||
| The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications | Q30838479 | ||
| Characterization of a putative phosphorylation switch: adaptation of SPOT synthesis to analyze PDZ domain regulation mechanisms | Q33304541 | ||
| A specificity map for the PDZ domain family | Q33373127 | ||
| Synthesis and application of peptide arrays: quo vadis SPOT technology | Q33444964 | ||
| Design of protein-interaction specificity gives selective bZIP-binding peptides. | Q34975999 | ||
| P433 | issue | 51 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9912-9916 | |
| P577 | publication date | 2010-12-01 | |
| 2010-12-17 | |||
| P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
| P1476 | title | Engineering peptide inhibitors to overcome PDZ binding promiscuity | |
| Engineering Peptide Inhibitors To Overcome PDZ Binding Promiscuity | |||
| P478 | volume | 49 |
| Q92996885 | A Multireporter Bacterial 2-Hybrid Assay for the High-Throughput and Dynamic Assay of PDZ Domain-Peptide Interactions |
| Q45996867 | A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45. |
| Q43832133 | Absolute free energies of biomolecules from unperturbed ensembles |
| Q34066239 | Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain |
| Q21145315 | Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity |
| Q35468530 | Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway |
| Q34925645 | Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor |
| Q52689243 | Cysteine modifiers suggest an allosteric inhibitory site on the CAL PDZ domain |
| Q41955342 | Hybrid Organic–Inorganic Inhibitors of a PDZ Interaction that Regulates the Endocytic Fate of CFTR |
| Q40995571 | MFPred: Rapid and accurate prediction of protein-peptide recognition multispecificity using self-consistent mean field theory |
| Q33895800 | Mapping receptor–ligand interactions with synthetic peptide arrays: Exploring the structure and function of membrane receptors |
| Q90623692 | MotifAnalyzer-PDZ: A computational program to investigate the evolution of PDZ-binding target specificity |
| Q50976881 | Optimization of the process of inverted peptides (PIPEPLUS) to screen PDZ domain ligands. |
| Q92102996 | PDZ Domains as Drug Targets |
| Q85511842 | Rhodium-catalyzed cysteine modification with diazo reagents |
| Q91913292 | Specificity in PDZ-peptide interaction networks: Computational analysis and review |
| Q27675510 | Stereochemical Determinants of C-terminal Specificity in PDZ Peptide-binding Domains: A NOVEL CONTRIBUTION OF THE CARBOXYLATE-BINDING LOOP |
| Q27680564 | Stereochemical Preferences Modulate Affinity and Selectivity among Five PDZ Domains that Bind CFTR: Comparative Structural and Sequence Analyses |
| Q27002520 | Synthetic peptide arrays for investigating protein interaction domains |
Search more.